Characterization and toxicity of hospital wastewaters in Turkey

Environmental Monitoring and Assessment

Volumn 189, Issue 2, 2017, Pages

  Yilmaz, Gulsum ^a,b   Kaya, Yasemin ^a   Vergili, Ilda ^a   Beril Gonder Z ^a   Özhan, Gül ^a   Ozbek Celik, Berna ^a   Altinkum, Serdar M ^b   Bagdatli, Yasar ^b   Boergers, Andrea ^c   Tuerk, Jochen ^c  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c Institute of Energy and Environmental Technology   (Germany)

Author keywords

Antibiotic resistant bacteria; Environmental risk assessment; Hospital wastewater; Pharmaceuticals; Toxicity

Indexed keywords

BACTERIA; CHEMICAL ANALYSIS; CORROSION INHIBITORS; DIAGNOSIS; DRUG PRODUCTS; DRUG THERAPY; EFFLUENT TREATMENT; EFFLUENTS; HAZARDOUS MATERIALS; HAZARDS; HOSPITALS; RISK ASSESSMENT; TOXICITY; WASTEWATER TREATMENT;

ANTIBIOTIC RESISTANCE BACTERIA; ANTIBIOTIC-RESISTANT BACTERIA; ENVIRONMENTAL RISK ASSESSMENT; HOSPITAL WASTEWATER; MULTIPLE ANTIBIOTIC RESISTANCES; MULTIPLE DRUG RESISTANCE; TOXICOLOGICAL ASSESSMENT; WASTEWATER TREATMENT PLANTS;

ANTIBIOTICS;

CEFTAZIDIME; CIPROFLOXACIN; CLARITHROMYCIN; DICLOFENAC; OFLOXACIN; SULFAPYRIDINE; TRIMETHOPRIM; ANTIINFECTIVE AGENT; PESTICIDE; WASTE DISPOSAL; WASTE WATER; WATER POLLUTANT;

ANTIBIOTIC RESISTANCE; BACTERIUM; DRUG; ENVIRONMENTAL RISK; HOSPITAL SECTOR; RISK ASSESSMENT; SOLID WASTE; TOXICITY; WASTEWATER TREATMENT PLANT;

ADSORPTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM; BIOREMEDIATION; CHEMICAL ANALYSIS; CONTROLLED STUDY; CYTOTOXICITY; ECOTOXICITY; EFFLUENT; HOSPITAL WASTE; MUTAGENIC ACTIVITY; NONHUMAN; RISK ASSESSMENT; TURKEY (REPUBLIC); WASTE COMPONENT REMOVAL; WASTE WATER; WASTE WATER TREATMENT PLANT; WATER ANALYSIS; WATER SAMPLING; ANALYSIS; CHEMISTRY; ENVIRONMENTAL MONITORING; HOSPITAL; SEWAGE; TOXICITY; TURKEY; WASTE DISPOSAL; WATER POLLUTANT;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; ENVIRONMENTAL MONITORING; HOSPITALS; MEDICAL WASTE DISPOSAL; PESTICIDES; RISK ASSESSMENT; TURKEY; WASTE DISPOSAL, FLUID; WASTE WATER; WATER POLLUTANTS, CHEMICAL;

EID: 85009517889     PISSN: 01676369     EISSN: 15732959     Source Type: Journal    
DOI: 10.1007/s10661-016-5732-2     Document Type: Article

References (73)

1. Al Aukidy, M., Verlicchi, P., & Voulvoulis, N. (2014). A framework for the assessment of the environmental risk posed by pharmaceuticals originating from hospital effluents. The Science of the Total Environment, 493, 54–64.
2. Alexander, J., Knopp, G., Dötsch, A., Wieland, A., & Schwartz, T. (2016). Ozone treatment of conditioned wastewater selects antibiotic resistance genes, opportunistic bacteria, and induce strong population shifts. The Science of the Total Environment, 559, 103–112.
3. Bagatini, M. D., Vasconcelos, T. G., Laughinghouse, H. D., Martins, A. F., & Tedesco, S. B. (2009). Biomonitoring hospital effluents by the Allium cepa L. test. Bulletin of Environmental Contamination and Toxicology, 82(5), 590–592.
4. Balcioglu, E. (2016). Assessment of polycyclic aromatic hydrocarbons (PAHs) in mussels (Mytilus galloprovincialis) of Prince Islands, Marmara Sea. Marine Pollution Bulletin, 109, 640–642.
5. Barraud, O., Casellas, M., Dagot, C., & Ploy, M.-C. (2013). An antibiotic-resistant class 3 integron in an Enterobacter cloacae isolate from hospital effluent. Clin. Microbial. Infec, 19, E306–E308.
6. Berendonk, T. U., Manaia, C. M., Merlin, C., Fatta-Kassinos, D., Cytryn, E., Walsh, F., Bürgmann, H., Sørum, H., Norström, M., Pons, M. N., Kreuzinger, N., Huovinen, P., Stefani, S., Schwartz, T., Kisand, V., Baquero, F., & Martinez, J. L. (2015). Tackling antibiotic resistance: the environmental framework. Nature Reviews. Microbiology, 13(5), 310–317.
7. Besse, J. P., Latour, J. F., & Garric, J. (2012). Anticancer drugs in surface waters: what can we say about the occurrence and environmental significance of cytotoxic, cytostatic and endocrine therapy drugs? Environment International, 39, 73–86.
8. Borecka, M., Siedlewicz, G., Halinski, L. P., Sikora, K., Pazdro, K., Stepnowski, P., & Bialk-Bielinska, A. (2015). Contamination of the southern Baltic Sea waters by the residues of selected pharmaceuticals: method development and field studies. Marine Pollution Bulletin, 94, 62–71.
9. Cabello, F. C., Godfrey, H. P., Tomova, A., Ivanova, L., Dölz, H., Millanao, A., & Buschmann, A. H. (2013). Antimicrobial use in aquaculture re-examined: its relevance to antimicrobial resistance and to animal and human health. Environmental Microbiology, 15, 1917–1942.
10. Clinical and Laboratory Standards Institute. (2009). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Guideline M7-A8. CLSI, Wayne, PA.
11. Coelhan, M., Strohmeier, J., & Barlas, H. (2006). Organochlorine levels in edible fish from the Marmara Sea. Turkey. Environ. Int., 32, 775–780.
12. Dancer, S. J. (2004). How antibiotics can make us sick: the less obvious adverse effects of antimicrobials chemotherapy. The Lancet Infectious Diseases, 4, 611–619.
13. Daughton, C. G., & Ternes, T. A. (1999). Pharmaceuticals and personal care products in the environment: agents of subtle change? Environmental Health Perspectives, 107(Suppl), 907–938.
14. DeLorenzo, M. E., & Fleming, J. (2008). Individual and mixture effects of selective pharmaceuticals and personal care products on the marine phytoplankton species Dunaliella tertiolecta. Archives of Environmental Contamination and Toxicology, 54, 203–210.
15. Devotes-Project-EU (2016). http://www.devotes-project.eu/sea-of-marmara/ Accessed 04 April 2016.
16. DHI (2011) Danish Nature Agency: hospital wastewater—BAT and development of treatment technologies. June 2011. Report prepared by DHI (in Danish).
17. Dizer, H., Wittekindt, E., Fischer, B., & Hansen, P. D. (2002). The cytotoxic and genotoxic potential of surface water and wastewater effluents as determined by bioluminescence, umu-assays and selected biomarkers. Chemosphere, 46(2), 225–233.
18. Ecotox Centre (2016). http://www.ecotoxcentre.ch/expert-service/quality-standards/proposals-for-acute-and-chronic-quality-standards/?_ga=1.24079859.875614127.1429693591 Accessed 21 October 2016.
19. Escher, B. I., Baumgartner, R., Koller, M., Treyer, K., Lienert, J., & McArdell, C. S. (2011). Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater. Water Research, 45, 75–92.
20. European Commission. (2003). Technical Guidance Document on Risk Assessment in support of Commission Directive 93/67/EEC on Risk Assessment for new notified substances, Commission Regulation (EC) No 1488/94 on Risk Assessment for existing substances, and Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market. Part II: Environmental Risk Assessment). Office for Official Publications of the European Communities, Luxembourg.
21. Fent, K., Weston, A. A., & Caminade, D. (2006). Ecotoxicology of human pharmaceuticals. Aquatic Toxicology, 76(2), 122–159.
22. Flückiger-Isler, S., & Kamber, M. (2012). Direct comparison of the Ames microplate format (MPF) test in liquid medium with the standard Ames preincubation assay on agar plates by use of equivocal to weakly positive test compounds. Mutation Research, 747, 36–45.
23. Fotakis, G., & Timbrell, J. A. (2006). In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicology Letters, 160(2), 171–177.
24. Gaw, S., Thomas, K. V., & Hutchinson, T. H. (2014). Sources, impacts and trends of pharmaceuticals in the marine and coastal environment. Phil. Trans. R. Soc, B369, 20130572.
25. Giuliani, F., Koller, T., Wurgler, F. E., & Widmer, R. M. (1996). Detection of genotoxic activity in native hospital waste water by the umu C test. Mutation Research, 368, 49–57.
26. Giulivo, M., Lopez de Alda, M., Capri, E., & Barceló, D. (2016). Human exposure to endocrine disrupting compounds: their role in reproductive systems, metabolic syndrome and breast cancer. A review. Environmental Research, 151, 251–264.
27. Goodfellow, M., Kämpfer, P., Busse, H. J., Trujillo, M. E., Suzuki, K. I., Ludwig, W., & Whitman, W. B. (2012). Bergey’s manual of systematic bacteriology. New York: Springer.
28. Gros, M., Petrović, M., Ginebreda, A., Barceló, D. (2010). Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes. Environ Int, 36, 15–26.
29. Grundfos BioBooster A/S. Report (2016). Full scale advanced wastewater treatment at Herlev Hospital—treatment performance and evaluation.
30. Gupta, P., Mathur, N., Bhatnagar, P., Nagar, P., & Srivastava, S. (2009). Genotoxicity evaluation of hospital wastewaters. Ecotoxicology and Environmental Safety, 72, 1925–1932.
31. Hakura, A., Shimada, H., Nakajima, M., Sui, H., Kitamoto, S., Suzuki, S., & Satoh, T. (2005). Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds. Mutagenesis, 20, 217–228.
32. Halling-Sørensen, B., Nielsen, N., Lansky, P. F., Ingerslev, F., Hansen, L., Lützhøft, H. C., & Jørgensen, S. E. (1998). Occurrence, fate and effects of pharmaceutical substances in the environment—a review. Chemosphere, 36, 357–394.
33. Harris, S., Morris, C., Morris, D., Cormican, M., & Cummins, E. (2014). Antimicrobial resistant Escherichia coli in the municipal wastewater system: effect of hospital effluent and environmental fate. The Science of the Total Environment, 468–469, 1078–1085.
34. Hartmann, A., Alder, A. C., Koller, T., & Widmer, R. M. (1998). Identification of fluoroquinolones antibiotics as the main source of umu C genotoxicity in native hospital wastewater. Environmental Toxicology and Chemistry, 17, 377–382.
35. Hartmann, A., Golet, E. M., Gartiser, S., Adler, A. C., Koller, T., & Widmer, R. M. (1999). Primary DNA damage but not mutagenicity correlates with ciprofloxacin concentrations in German hospital wastewaters. Archives of Environmental Contamination and Toxicology, 36, 115–119.
36. Heberer, T. (2002). Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicology Letters, 131(1), 5–17.
37. Hernando, M. D., Mezcua, M., Fernandez-Alba, A. R., & Barcelo, D. (2006). Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments. Talanta, 69, 334–342.
38. Jolibois, B., & Guerbet, M. (2005). Evaluation of industrial, hospital and domestic wastewater genotoxicity with the Salmonella fluctuation test and the SOS chromotest. Mutation Research, 565(2), 151–162.
39. Jolibois, B., Guerbet, M., & Vassal, S. (2003). Detection of hospital wastewater genotoxicity with the SOS chromotest and Ames fluctuation test. Chemosphere, 51, 539–543.
40. KL (2013) Local Government Denmark (KL): hospital wastewater—tool for sewer connection permits. December 2013, (In Danish)
41. KL (2013a) Local Government Denmark (KL): proposal for administrative basis for pharmaceuticals in hospital wastewater, recommended maximum concentration for connection to sewer, input for KL working group concerning hospital wastewater. Prepared by DHI, June 2013, (in Danish)
42. Kovalova, L., Siegrist, H., Singer, H., Wittmer, A., & McArdell, C. S. (2012). Hospital wastewater treatment by membrane bioreactor: performance and efficiency for organic micropollutant elimination. Environmental Science & Technology, 46(3), 1536–1545.
43. Kumar, A., & Xagoraraki, I. (2010). Pharmaceuticals, personal care products and endocrine-disrupting chemicals in U.S. surface and finished drinking waters: a proposed ranking system. The Science of the Total Environment, 408, 5972–5989.
44. Kümmerer, K. (2001). Drugs in the environment: emission of drugs, diagnostic aids and desinfectants into wastewater by hospitals in relation to other sources—review. Chemosphere, 45, 957–969.
45. Lin, J., & Biyela, P. T. (2005). Convergent acquisition of antibiotic resistance determinants amongst the Enterobacteriaceae isolates of the Mhlathuze River, Kwazulu-Natal (RSA). Water SA, 31(2), 25–260.
46. Mater, N., Geret, F., Castillo, L., & Leszkowicz, A. (2014). In vitro tests aiding ecological risk assessment of ciprofloxacin, tamoxifen and cyclophosphamide in range of concentrations released in hospital wastewater and surface water. Environment International, 63, 191–200.
47. Mendoza, A., Acena, J., Perez, S., Lopez de Alda, M., Barcelo, D., & Gil, A. (2015). Pharmaceuticals and iodinated contrast media in a hospital wastewater: a case study to analyse their presence and characterise their environmental risk and hazard. Environmental Research, 140, 225–241.
48. Nielsen, U., Hastrup, C., Klausen, M. M., Pedersen, B. M., Kristensen, G. H., Jansen, J. L., Bak, S. N., & Tuerk, J. (2013). Removal of APIs and bacteria from hospital wastewater by MBR plus O(3), O(3) + H(2)O(2), PAC or ClO(2). Water Science and Technology, 67(4), 854–862.
49. Oliveira, T. S., Murphy, M., Mendola, N., Wong, W., Carlson, D., & Waring, L. (2015). Characterization of pharmaceuticals and personal care products in hospital effluent and wastewater influent/effluent by direct-injection LC-MS-MS. The Science of the Total Environment, 518–519, 459–478.
50. Orias, F., & Perrodin, Y. (2013). Characterisation of the ecotoxicity of hospital effluents: a review. The Science of the Total Environment, 454–455, 250–276.
51. Orias, F., & Perrodin, Y. (2014). Pharmaceuticals in hospital wastewater: their ecotoxicity and contribution to the environmental hazard of the effluent. Chemosphere, 115, 31–39.
52. Otansev, P., Taşkın, H., Başsarı, A., & Varinlioğlu, A. (2016). Distribution and environmental impacts of heavy metals and radioactivity in sediment and seawater samples of the Marmara Sea. Chemosphere, 154, 266–275.
53. Rahman, M. F., Yanful, E. K., & Jasim, S. Y. (2009). Endocrine disrupting compounds (EDCs) and pharmaceuticals and personal care products (PPCPs) in the aquatic environment: implications for the drinking water industry and global environmental health. Journal of Water and Health, 07(2), 224–243.
54. Repetto, G., Del Peso, A., & Zurita, J. L. (2008). Neutral red uptake assay for the estimation of cell viability/cytotoxicity. Nature Protocols, 3(7), 1125–1131.
55. Rose, J. M., Gast, R. J., Bogomolni, A., Ellis, J. C., Lentell, B. J., Touhey, K., & Moore, M. (2009). Occurrence and patterns of antibiotic resistance in vertebrates off the northeastern United States coast. FEMS Microbiology Ecology, 67, 421–431.
56. Rota, C., Yanguela, J., Blanco, D., Carraminana, J. J., Arino, A., & Herrera, A. (1996). High prevalence of multiple resistances to antibiotics in 144 Listeria isolates from Spanish dairy and meat products. Journal of Food Protection, 59, 938–943.
57. Santos, L. H., Gros, M., Rodriguez-Mozaz, S., Delerue-Matos, C., Pena, A., Barceló, D., & Montenegro, M. C. (2013). Contribution of hospital effluents to the load of pharmaceuticals in urban wastewaters: identification of ecologically relevant pharmaceuticals. The Science of the Total Environment, 461–462, 302–316.
58. Seidel, U., Ante, S., Börgers, A., Herbst, H., Matheja, A., Remmler, F., Sayder, B., Türk, J. (2013). Abschlussbericht zum Forschungsvorhaben “Analyse der Eliminationsmöglichkeiten von Arzneimitteln in den Krankenhäusern in NRW (TP 3)”, gerichtet an das Ministerium für Klimaschutz, Umwelt, Landwirtschaft, Natur- und Verbraucherschutz des Landes Nordrhein-Westfalen (MKULNV), AZ IV-7-042 600 001C, Vergabenummer 08/0581.
59. Sharma, P., Mathur, N., Singh, A., Bhatnagar, P., Atri, R., & Sogani, M. (2014). Efficiency analysis of a hospital effluent treatment plant in reducing genotoxicity and cytotoxicity of hospital wastewaters. Intl. J. of Adv. Biotec. and Res, 5(3), 371–380.
60. Sharma, P., Mathur, N., Singh, A., Sogani, M., Bhatnagar, P., Atri, R., & Pareek, S. (2015). Monitoring hospital wastewaters for their probable genotoxicity and mutagenicity. Environmental Monitoring and Assessment, 187(1), 4180–4190.
61. Sui, Q., Wang, B., Zhao, W., Huang, J., Yu, G., & Deng, S. (2012). Identification of priority pharmaceuticals in the water environment of China. Chemosphere, 89, 280–286.
62. Tacconelli, E., Angelis, G. D., Cataldo, M. A., Mantengoli, E., Spanu, T., Pan, A., Corti, G., Radice, A., Stolzuoli, L., & Antinori, S. (2009). Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study. Antimicrobial Agents and Chemotherapy, 53, 4264–4269.
63. Taşkın, Ö. S., Aksu, A., & Balkıs, N. (2011). Metal (Al, Fe, Mn and Cu) distributions and origins of polycyclic aromatic hydrocarbons (PAHs) in the surface sediments of the Marmara Sea and the coast of Istanbul, Turkey. Marine Pollution Bulletin, 62, 2568–2570.
64. Türk, J., Dazio, M., Dinkel, F., Ebben, T., Hassani, V., Herbst, H., Hochstrat, R., Matheja, A., Montag, D., Remmler, F., Schaefer, S., Schramm, E., Vogt, M., Werbeck, N., Wermter, P., Wintgens, T. (2013). Abschlussbericht zum Forschungsvorhaben “Volkswirtschaftlicher Nutzen der Ertüchtigung kommunaler Kläranlagen zur Elimination von organischen Spurenstoffen, Arzneimitteln, Industriechemikalien, bakteriologisch relevanten Keimen und Viren (TP 9)”, gerichtet an das Ministerium für Klimaschutz, Umwelt, Landwirtschaft, Natur und Verbraucherschutz des Landes Nordrhein-Westfalen (MKULNV), AZ IV-7-042 600 001I, Vergabenummer 08/0581.
65. Türkmen, M., Türkmen, A., Tepe, Y., Ateş, A., & Gökkuş, K. (2008). Determination of metal contaminations in sea foods from Marmara, Aegean and Mediterranean Seas: twelve fish species. Food Chemistry, 108, 794–800.
66. Umbuzeiro, G. D. A., Rech, C. M., Correia, S., Bergamasco, A. M., Cardenette, G. H. L., Flückiger, S., & Kamber, M. (2010). Comparison of the Salmonella/microsome microsuspension assay with the new microplate fluctuation (MPF) protocol for testing the mutagenicity of environmental samples. Environmental and Molecular Mutagenesis, 51, 31–38.
67. USGS (2016). Endocrine disruption found in fish exposed to municipal wastewater, Accessed 04. October 2016.
68. Uzar, N. K., Abudayyak, M., Akcay, N., Algun, G., & Özhan, G. (2015). Zinc oxide nanoparticles induced cyto- and genotoxicity in kidney epithelial cells. Toxicology Mechanisms and Methods, 25(4), 334–339.
69. Van Meerloo, J., Kaspers, G. J., & Cloos, J. (2011). Cell sensitivity assays: the MTT assay. Methods in Molecular Biology, 731, 237–245.
70. Verlicchi, P., Al Aukidy, M., Galletti, A., Petrovic, M., & Barceló, D. (2012). Hospital effluent: investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment. The Science of the Total Environment, 430, 109–118.
71. Verlicchi, P., Al Aukidy, M., & Zambello, E. (2015). What have we learned from worldwide experiences on the management and treatment of hospital effluent?—an overview and a discussion on perspectives. The Science of the Total Environment, 514, 467–491.
72. WHO (2016). Antimicrobial resistance, Accessed 10. October 2016.
73. Yang, G. C. C., Tsai, H.-J., & Chang, F.-K. (2015). Occurrence of triclosan in the tropical rivers receiving the effluents from the hospital wastewater treatment plant. Environmental Monitoring and Assessment, 187, 151.